(CNO) CNO Financial - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US12621E1038

CNO EPS (Earnings per Share)

This chart shows the EPS (Earnings per Share) of CNO over the last 5 years for every Quarter.

CNO Revenue

This chart shows the Revenue of CNO over the last 5 years for every Quarter.

CNO: Health Insurance, Life Insurance, Annuities, Long-Term Care

CNO Financial Group Inc (NYSE:CNO) is a leading provider of insurance and financial services products tailored to the needs of middle-income Americans, particularly those in pre-retirement and retirement. Through its subsidiaries, the company offers a diverse range of products, including Medicare supplement, long-term care insurance, life insurance, and annuities, which are sold through various channels, including phone, online, and in-person sales.

The companys product portfolio is designed to address the specific needs of its target market, with a focus on providing supplemental health and life insurance products to individuals and businesses. CNO Financial Groups products are marketed under well-established brand names, including Bankers Life, Washington National, and Colonial Penn, which have a strong presence in the US insurance market.

From a business perspective, CNO Financial Group has a strong track record of serving the middle-income market, with a particular emphasis on retirees and pre-retirees. The companys products are designed to provide financial security and stability, and its distribution channels are geared towards providing a personalized sales experience. With a market capitalization of $3.68 billion, CNO Financial Group is a significant player in the US life and health insurance industry.

Analyzing the and , we can observe that CNO Financial Groups stock price is currently trading at $38.17, with a relatively stable short-term trend, as indicated by its SMA20 and SMA50. The stocks ATR of 0.91 suggests a moderate level of volatility. Considering the companys P/E ratio of 12.99 and forward P/E of 9.71, we can infer that the stock is relatively undervalued compared to its earnings growth prospects. With a RoE of 12.04, the company demonstrates a decent level of profitability. Based on these metrics, we forecast that CNO Financial Groups stock price will experience a moderate increase in the short term, potentially reaching $42.00 within the next 6-12 months, driven by its stable business model and improving earnings prospects.

Our forecast is based on a combination of technical and fundamental analysis, taking into account the companys strong brand presence, diversified product portfolio, and relatively undervalued stock price. However, its essential to note that the insurance industry is subject to various regulatory and market risks, which may impact CNO Financial Groups future performance. As such, investors should carefully consider these factors before making any investment decisions.

Additional Sources for CNO Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

CNO Stock Overview

Market Cap in USD 3,758m
Sector Financial Services
Industry Insurance - Life
GiC Sub-Industry Life & Health Insurance
IPO / Inception 1987-01-01

CNO Stock Ratings

Growth Rating 81.6
Fundamental 16.8
Dividend Rating 64.4
Rel. Strength 11.3
Analysts 2.83 of 5
Fair Price Momentum 37.48 USD
Fair Price DCF 96.69 USD

CNO Dividends

Dividend Yield 12m 1.76%
Yield on Cost 5y 4.89%
Annual Growth 5y 6.03%
Payout Consistency 100.0%
Payout Ratio 15.3%

CNO Growth Ratios

Growth Correlation 3m -48.4%
Growth Correlation 12m 76.4%
Growth Correlation 5y 79.2%
CAGR 5y 22.60%
CAGR/Max DD 5y 0.59
Sharpe Ratio 12m 0.75
Alpha 29.45
Beta 0.854
Volatility 26.56%
Current Volume 622.2k
Average Volume 20d 608.2k
What is the price of CNO shares?
As of June 16, 2025, the stock is trading at USD 36.88 with a total of 622,231 shares traded.
Over the past week, the price has changed by -2.95%, over one month by -4.40%, over three months by -10.45% and over the past year by +37.69%.
Is CNO Financial a good stock to buy?
Neither. Based on ValueRay´s Fundamental Analyses, CNO Financial is currently (June 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 16.76 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of CNO is around 37.48 USD . This means that CNO is currently overvalued and has a potential downside of 1.63%.
Is CNO a buy, sell or hold?
CNO Financial has received a consensus analysts rating of 2.83. Therefor, it is recommend to hold CNO.
  • Strong Buy: 0
  • Buy: 1
  • Hold: 4
  • Sell: 0
  • Strong Sell: 1
What are the forecasts for CNO share price target?
According to our own proprietary Forecast Model, CNO CNO Financial will be worth about 42.5 in June 2026. The stock is currently trading at 36.88. This means that the stock has a potential upside of +15.13%.
Issuer Target Up/Down from current
Wallstreet Target Price 44 19.3%
Analysts Target Price 44.2 19.8%
ValueRay Target Price 42.5 15.1%